Stuart Carroll a senior health economist and epidemiologist with 20 years of experience in health policy, market access, public affairs, health economics and outcomes research. He is currently the Director for Market Access and Policy Affairs for Moderna in the UK and Ireland, and specialises in infectious diseases, vaccines, therapeutics, rare diseases and mental health. Stuart is also a Senior Visiting Research Fellow at the Office of Health Economics, providing strategic policy and analytical advice, and is also a Fellow at the Royal Society of Public Health and Royal Society of Arts. In 2015 and 2019, Stuart was elected as Councillor for Boyn Hill, Maidenhead where he has served as the Cabinet Member for Adult Social Care, Health, Mental Health, Children Services and Education as well as Vice Chair of Cabinet. He is a mental health and suicide prevention first aider and a strong advocate in this area.  Stuart has held a variety of leadership roles across the health and pharmaceutical industry, including at Sanofi-Pasteur MSD, Sanofi and Biogen. Prior to joining Moderna, he was a Senior Expert Policy & Strategy Adviser in the UK Government’s Vaccines Taskforce and the Antiviral and Therapeutic Taskforces. Stuart holds a First Class BA Honours in Politics and Economics (University of Northumbria at Newcastle), a Masters with Distinction in Health Economics and Epidemiology (University of York) and an MBA with Distinction from Imperial Business School.  Stuart is also currently studying a PhD in social sciences and public health at the University of Nottingham under the supervision of Sir Professor Jonathan Van Tam with a core research focus on the COVID-19 pandemic and vaccination policy.